ABSTRACT On the basis of animal studies, we postulated that the size of the perfusion field (risk area) of an occluded coronary artery would be an important determinant of outcome in patients with acute myocardial infarction. To test this hypothesis, we measured size of the risk area in 27 patients with acute myocardial infarction by the intracoronary injection of 9fmTc-macroaggregated albumin and gated nuclear imaging. After injection of the albumin spheres (5.3 + 1.4 hr after the onset of chest pain) streptokinase was administered and in 16 of 27 patients (59%) effective thrombolysis was achieved. Since none of the patients had evidence of a prior acute myocardial infarction, the 3 day nuclear left ventricular ejection fraction (LVEF) was considered an index of infarct size. Response to thrombolysis was analyzed according to success 
ly, it has been shown that knowledge of the anatomic site of occlusion of the coronary artery cannot be used to predict the size of the risk area.36 In animals it was observed that if the risk area (as defined by barium angiography) was less than 18% to 20% of the left ventricular mass, no infarction occurred.6 If the risk area was greater than 20% there was a close linear relationship between the size of the risk area and ultimate infarct size.'`' Experimental interventions can shift both the slope and intercept of this infarct/risk relationship in both unfavorable and favorable directions.7-9 Most approaches to assessing risk area require excision of the heart.5 1012 Lee et al.,5 using postmortem autoradiography, demonstrated that there was a linear relationship between risk area and subsequent infarct size in patients who suffered fatal infarctions. Although size of the risk area has been demonstrated to be an important variable that determines infarct size, efforts to determine risk area in patients with acute myocardial infarction have been hampered by lack of a suitable method.
We have recently developed and validated in animals an accurate and reproducible experimental method for determining the in vivo, premortem risk area by use of intracoronary administration of 99mTc-macroaggregated albumin (TcMAA) in conjunction with gated nuclear imging. '3 We have introduced this technique into the cardiac catheterization laboratory where risk area was determined in patients with acute myocardial infarction before they received thrombolytic therapy with intracoronary streptokinase.
The purpose of this study was to extend the concept to humans that size of the risk area, determined in vivo, is a key determinant of the outcome of acute myocardial infarction. In addition, we examined specific factors that might influence this variable, such as the coronary artery involved and the site of occlusion within a given coronary vessel. We also assessed the ability of several commonly available clinical indexes to predict size of the risk area.
Methods
Patient selection. The study group consisted of 27 patients who were admitted for intracoronary thrombolytic therapy of acute myocardial infarction at the University of Iowa Medical center between July 1983 and November 1984. Criteria for admission to this study were as follows:
(1) History of prolonged chest pain (greater than 30 min) and symptoms consistent with acute myocardial infarction. (2) Onset of chest pain less than 8 hr preceding arrival at the cardiac catheterization laboratory. Thus 27 patients studied in a consecutive manner constituted the final study group. Protocol. In the emergency room all patients received standard therapy for acute myocardial infarction, which included intravenous lidocaine (75 to 100 mg intravenous bolus followed by a 2 mg/min drip), oxygen via a nasal cannula (4 1 /min), and morphine sulfate intravenously as needed to control pain. Before catheterization, patients who were hemodynamically stable were premedicated with 50 mg iv diphenhydramine and 25 mg subcutaneous promethazine.
Catheterization protocol. By the Seldinger femoral-arterial and venous approach, the following steps were sequentially performed after administration of a 5000 unit bolus of intravenous heparin. Initial assessment of right and left heart pressures was followed by left ventricular cineangiography in the 40 degree right anterior oblique projection. Selective coronary angiography was performed in multiple projections. After angiographic evaluation, 400 gzg of intracoronary nitroglycerin was delivered into the infarct-related artery that remained totally occluded. If the artery remained completely occluded, then 10 mCi of TcMAA was delivered in divided doses into the left main and right coronary ostia via selective coronary catheters. After administration of the TcMAA, an intracoronary bolus of 20,000 units of streptokinase was administered into the infarctrelated artery, followed by an infusion of intracoronary streptokinase at 4000 units/min. Every 15 min thereafter if reperfusion failed to occur an additional bolus of 20,000 units was administered and the intracoronary infusion was continued. If reperfusion was unsuccessful this sequence was continued for a total of 1½/2 hr (480,000 units). If the artery reperfused, streptokinase was administered for an additional 30 min after angiographic evidence of vessel patency. All patients remained systemically heparinized for 10 days after cardiac catheterization and an activated partial thromboplastin time of 2 to 21/2 times normal was maintained.
Risk area protocol: administration of TcMAA. A total of 10 mCi of intracoronary TcMAA (200,000 particles) was administered to each patient. Quality control of the macroaggregates was assured by assessment of the injectate for particle size, number, and labeling efficiency. Before the intracoronary injection of TcMAA, the angiographic catheter was optimally positioned to avoid selective injection or noticeable contrast streaming. After the final contrast injection, 1 min was allowed to elapse before the injection of the radiolabeled particles to minimize any potential effect of contrast-induced coronary vasodilatation on particle distribution. Thereafter the residual contrast was aspirated from the coronary catheter and the TcMAA was slowly infused into the coronary artery over a period of 15 to 30 sec. We administered 8
Vol. 75, No. 5, May 1987mCi of TcMAA into the left coronary artery and 2 mCi of TcMAA into the right coronary. The catheter was then flushed of residual radioactivity with a slow injection of 10 ml of normal saline. Pulmonary capillary wedge pressure, arterial blood pressure, and the electrocardiogram were continuously monitored before and for 2 min after injection of the TcMAA.
Imaging of the risk area. Gated images were obtained in two projections with the use of a Searle low-energy small-field-ofview camera (Siemens, LEM) interfaced with a Medical Data System (MDS-A2) computer. The camera's energy analyzers were set at 140 keV with a 15% window. A low-energy, allpurpose, parallel-hole collimator was used. Twelve gated images per cardiac cycle were acquired in a 64 x 65 matrix with the use of byte mode data recording at 1.5 to 2 magnification. Each of the twelve gated images contained 200,000 counts per frame. Imaging time per projection ranged between 2 and 5 min. Administration of the TcMAA did not significantly delay institution of streptokinase therapy, because gated imaging was performed during continuous administration of the intracoronary infusion of streptokinase. Images were obtained in the left anterior oblique (LAO) and right anterior oblique (RAO) projections. For images acquired in the left anterior oblique projection (30 to 45 degrees LAO), the camera face was positioned to obtain maximal separation of the right and left ventricles as well as optimal visualization of the septum. In this projection the right ventricular free wall was also well visualized. In the right anterior oblique projection the camera was positioned to obtain the greatest surface area of the ventricle.
Assessment of coronary angiograms. Coronary arteriograms were analyzed by two observers. A vessel was said to be significantly diseased if the luminal diameter was reduced by more than 50%. The site of coronary artery occlusion was graded as either proximal or mid vessel, according to the American Heart Association classification.14 For the right coronary artery, proximal occlusions were defined as occurring between the coronary ostium and the first right ventricular branch and mid vessel occlusions as between the first right ventricular branch and the acute marginal artery. For the left anterior descending artery occlusions were proximal if they occurred between the left main ostium and the first septal perforator and mid vessel if they were between the first septal and second diagonal branch. Collateral vessels were said to be present if any segment of the infarct-related artery distal to the occlusion filled in a retrograde fashion.
Analysis and assessment of LVEF. LVEF was assessed by radionuclide ventriculography on the third hospital day for each surviving patient. Gated resting ventriculograms were obtained by labeling of red cells in vivo with 25 mCi of 99mTc. 1I The left ventricular ejection fraction was calculated from the 45 degree LAO image. The accuracy and precision of these methods have been described elsewhere. 16. 17 Analysis of risk area. The technique for analyzing the area at risk in vivo has been previously described.'3 Briefly, for patients with either left anterior descending or circumflex coronary artery occlusion the LAO view was used to assess the risk area; for patients with right coronary artery occlusion the RAO view was analyzed. The end-diastolic frame of each of these studies was isolated and the ventricular perimeter was traced with the light pen. In the LAO projection the ventricular cavity and the hypoperfused zone were delineated. For RAO projections, only the epicardial boundaries and the hypoperfused zone were defined. The left ventricular risk area was calculated as the planimetric ratio between the area of the hypoperfused zone and the projected area of the entire left ventricular myocardium.
Patients were divided into two groups based on the size of the area at risk: patients with small risk areas, i.e., those less than 25% of left ventricular wall area, and patients with large risk areas, or those greater than 25% of the left ventricular wall area.
Relationship between the risk area and the presenting electrocardiogram, hemodynamics, and acute LVEF Electrocardiograms. A 12-lead electrocardiogram was obtained in all patients while they were undergoing evaluation in the emergency room. The electrocardiogram was analyzed according to the following criteria: (1) sum of ST segment elevation in all involved leads, (2) presence of significant (< 0.03 mm/sec wide) q waves in the infarct-related leads, (3) sum of the leads with both ST segment elevation and q waves. Patients with left or right bundle branch block were excluded from ECG analysis (n = 2). Hemodynamics. Hemodynamic evaluation was done before institution of thrombolytic therapy. Presenting heart rate was evaluated from the initial electrocardiogram. Arterial blood pressure was recorded in the catheterization laboratory after access to the femoral artery had been obtained. Cardiac output was determined by the thermodilution technique. The cardiac output was determined by averaging five sequential measurements of cardiac output. Statistical analysis. Students t-test (paired or unpaired) was used to compare two groups with approximately normal distribution. The correlation between the risk area and 3 day radionuclide LVEF, as well as the relationships between ECG variables, cardiac index, angiographic LVEF, and heart rate and blood pressure were analyzed by the least square method of determining linear regression. The significance of the correlation coefficient value, slope, and y intercept were calculated. Nonparametric group comparisons were made when appropriate with the use of the Mann-Whitney test. Chi-square analysis was performed for data in a 2 x 2 contingency table. Significance was accepted at a level of p < .05. Data are presented as the mean -+ SD.
Results
Patient characteristics. The patient data were analyzed according to the following major variables: immediate success or failure of thrombolysis (determined at the time of leaving the catheterization laboratory), size of the risk area of the infarct-related artery, number of significantly diseased vessels other than the infarct-related artery, and collateral vessels to infarctrelated artery (table 1). The average age of the patients was 57 + 11 years (mean 55.7 ± 11; women 59.9 ± 12). The average time from onset of chest pain to streptokinase infusion was 5.25 + 1.4 hr (men 5.2 + 1.5; women 5.2 + 1. 1). At the conclusion of streptokinase therapy a systematic fibrinolytic state was achieved in all patients, as evidenced by a persistent ADiseased vessel defined as greater than 50% narrowing of luminal diameter of a non-infarct-related artery.
BCollateral to infarct-related artery visually apparent.
CStatistically significant at p < .05. All patients in this group had right coronary artery occlusions.
depression of fibrinogen and elevation of levels of fibrin split products.`5 Analysis of risk area, hemodynamics, and the coronary arteriogram. The mean heart rates for patients with small vs those with large risk areas were 84 ± 14 and 82 ± 14 beats/min (p = NS). Likewise, the mean arterial blood pressures for these two groups were 95 ± 11 and 91 ± 14 mm Hg (p = NS). There was no statistically significant difference in the frequency of two-or three-vessel coronary artery disease in patients with small risk areas as compared with those with large risk areas (table 1) . As a group, the patients with small risk areas (< 25%) usually had either right coronary or circumflex coronary occlusions and patients with large risk areas had occlusions of the left anterior descending artery (figure 1). In patients with right coronary artery occlusions, the mean risk areas for proximal and midvessel occlusion were 20 ± 2% and 17 ± 5% (p = NS) (figure 1). For patients with left anterior descending artery occlusions, the mean risk areas for proximal and midvessel occlusions were 38 ± 8% and 33 ± 14% (p = NS) (figure 1). It 14% to 49% of the left ventricular surface area (mean 39 ± 5%) (figure 2). There was a statistically significant difference in size of the risk area for patients with left anterior descending occlusions and those with right and circumflex artery occlusions (p < .001), although some overlap was present (figure 1). When size of the risk area was evaluated as a function of the success or failure of coronary artery reperfusion, the size in the two groups was approximately equal ( figure 3, left) . When patients were grouped with regard to large and small risk areas, the number of patients in whom reperfusion was successful and in whom it was unsuccessful was similar ( figure 3, right) . However, when these patients were stratified according to size of the risk area, as expected a large separation was observed between the mean areas for each group (17.6% vs 39.2%, small vs large).
Relationship between the 3 day LVEF and size of the risk area. When 3 day LVEF was evaluated as a function of the success or failure of coronary artery reperfusion, no statistically significant difference was observed ( figure 4, left) . However, when patients were stratified on the basis of the size of the risk area rather than success or failure of reperfusion, a statistically significant difference in 3 day LVEF was noted (p < .001) ( figure 4, left) figure 6 ). The relationship between risk area and 3 day ejection fraction in all patients, regardless of outcome of thrombolytic therapy, was represented by r = .77, y -0.87x + 69 (figure 5). For patients who underwent successful thrombolysis the relationship between size of the risk area and 3 day ejection fraction was weaker (r = .69, y -0.72x + 66). There was no statistically significant difference between the various slopes or intercepts of these regression equations.
Mortality. No patient died during cardiac catheterization. Five patients died from cardiogenic causes during the course of the study. All patients who died had risk areas greater than 33% regardless of reperfusion status (figure 1). Five of thirteen patients with risk areas greater than 33% died within 7 days of admission. Of these five who died, coronary artery reperfusion was successful in two and failed in three. Four of five patients had proximal occlusions of the left anterior descending artery. The mean risk area of the patients who died was greater (41 ± 3%) than the risk area of the surviving patients (24 + 12%, p < .005). Postmortem examinations were obtained in the two patients who died of cardiogenic shock within 24 hr of myocardial infarction and the determination of risk area. Based on the residual TcMAA radioactivity that remained in the myocardium, postmortem autoradiography in these patients demonstrated left ventricular risk areas of 43% and 46%, respectively. The gated and diastolic risk area obtianed at the time of catheterization in these same patients was 42% and 43%, respectively.
Long-term follow-up. The average duration of follow-up in the 24 surviving patients was 14.7 + 4.9 months (range 6.5 to 23 months). All patients who survived the fourth hospital day (85%) were alive at follow-up. No patient with right coronary artery occlusion died because of cardiac dysfunction.
Discussion
There are three salient findings of this study: anatomy cannot be used to accurately predict size of the risk area. Thus, this study in humans suggests that quantitative measurements of risk area may be critical in studies directed toward evaluating the efficacy of clinical infarct-limiting strategies. In view of our findings, development of rapid, precise approaches to the assessment of the size of the risk area, such as tomographic imaging of intravenously administered radionuclides, should be encouraged.
